One Neuroscience and Pain Learning Zone
Expert Opinion
Interview with Dr Wallace Brownlee, Neurologist and Multiple Sclerosis Specialist, Queen's Square MS Centre, London
Patients on disease-modifying therapy for MS: Improving vaccine responses
Learn more about the impact of COVID-19 on multiple sclerosis
SARS-COV-2 vaccine response and disease-modifying therapies - learn more from the expert
Adaptive B cell and T cell immune responses to vaccination: Are they affected by DMTs for MS?
Treatment of pregnant or breastfeeding MS patients: Learn more and prescribe with confidence
Family planning in MS patients: Understand the key considerations
Active disease and multiple sclerosis treatment during pregnancy: Yes or No?
Video highlights:
the implications of COVID-19 for patients on disease-modifying therapies for multiple sclerosis (MS) / key considerations for family planning decisions in patients with MS / safety of MS therapies during pregnancy and breastfeeding
Developed by EPG Health for Medthority. This content has been developed independently of the sponsor Novartis Pharma AG, who have had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.